Clinical trial
Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
NCT05652348 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
- Lead sponsor
- Technische Universität Dresden
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 8, 2022
- Completion date
- December 31, 2028
- Enrollment
- 48 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, gastric cancer, peritoneal carcinomatosis